As an SGLT2 inhibitor, ertugliflozin carries the same warnings as others in the class, including the potential for elevations in LDL cholesterol, as well as an increased risk of ketoacidosis, acute kidney injury and renal failure, urosepsis and pyelonephritis, genital mycotic infections, lower-limb amputation, and severe hypotension
Understanding your MC4R and FTO variants also illuminates whether your appetite predisposition reflects genuinely elevated hunger hormone signalingan insight that reframes weight loss as a medical condition being treated, not a personal willpower failure
10.1186/s12882-025-04166-4 67 RaniP.Koulmane LaxminarayanaS
The single biggest factor affecting results is consistency daily evening application produces dramatically better outcomes than irregular use
Vitaly Pozdeev (Uni.Lu), Dominique Revets (LIH), Thomas Cerutti (LIH), and Gert Van Isterdael (VIB) for tissue section microscopy and FACS sorting